phenelzine has been researched along with Claustrophobia in 76 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic response to phenelzine sulfate was evaluated during 6 months' treatment of 35 outpatients meeting DSM-III criteria for panic disorder or agoraphobia with panic attacks." | 9.06 | Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. ( Buigues, J; Vallejo, J, 1987) |
| "The therapeutic response to phenelzine sulfate was evaluated during 6 months' treatment of 35 outpatients meeting DSM-III criteria for panic disorder or agoraphobia with panic attacks." | 5.06 | Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. ( Buigues, J; Vallejo, J, 1987) |
| " Twenty-six out of 28 out-patients with agoraphobia and social phobias who had originally been treated with phenelzine or placebo in a double-blind clinical trial were followed up for a mean period of one year." | 5.04 | Symptomatic treatment of agoraphobia and social phobias: a follow-up study. ( Steinberg, D; Tyrer, P, 1975) |
| "Reports that imipramine and phenelzine prevent panic attacks in agoraphobia suggest the possibility that agoraphobia and/or panic disorder might be a clinical manifestation of underlying depression." | 3.66 | The dexamethasone suppression test in panic disorder and agoraphobia. ( Cameron, OG; Curtis, GC; Nesse, RM, 1982) |
| "Phenelzine was widely superior to both atenolol and placebo on independent rater analyses and, to a lesser extent, on self-report, with no significant differences between atenolol and placebo." | 2.67 | Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. ( Campeas, R; Davies, S; Fyer, A; Gorman, J; Gully, R; Hatterer, J; Hollander, E; Liebowitz, MR; Papp, L; Schneier, F, 1992) |
| "Phenelzine appeared to be a particularly effective treatment for the generalized form of social phobia." | 2.67 | Phenelzine and atenolol in social phobia. ( Campeas, R; Fyer, A; Gorman, J; Hatterer, J; Hollander, E; Liebowitz, MR; Papp, L; Schneier, F, 1990) |
| "Atenolol was effective in one patient." | 2.67 | Pharmacotherapy of four men with paruresis. ( Campeas, RB; Fyer, AJ; Gorman, JM; Hatterer, JA; Hollander, E; Liebowitz, MR; Papp, LA; Schneier, FR, 1990) |
| "Isocarboxazid was replaced by placebo, using double-blind procedure." | 2.67 | Efficacy of combined antidepressant therapy in resistant neurotic disorder. ( Murphy, S; Tyrer, P, 1990) |
| "Sixty patients, 30 with depressive neurosis, 15 with anxiety neurosis and 15 with phobic anxiety states, were treated with the monoamine oxidase inhibitor, phenelzine, in two different dosage schedules for four weeks." | 2.65 | Clinical and pharmacokinetic factors affecting response to phenelzine. ( Gardner, M; Lambourn, J; Tyrer, P; Whitford, M, 1980) |
| "Endogenous anxiety (anxiety hysteria, agoraphobia with panic attacks) is characterized by sudden, spontaneous panic attacks accompanied by multiple autonomic symptoms, overwhelming fear, a flight response, and polyphobic behavior." | 2.65 | Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. ( Ballenger, J; Jacobsen, G; Sheehan, DV, 1980) |
| " Clinical response to phenelzine is related to platelet MAO inhibition and dosage per unit body weight." | 2.64 | Clinical pharmacology of phenelzine. ( Bartlett, D; Ives, JO; Nies, A; Ravaris, CL; Robinson, DS, 1978) |
| "The only side effects of treatment were mild constipation and weight gain." | 1.28 | Phenelzine treatment of elective mutism: a case report. ( Golwyn, DH; Weinstock, RC, 1990) |
| "Phenelzine was administered to 11 patients meeting DSM-III criteria for social phobia in open clinical trials." | 1.27 | Phenelzine in social phobia. ( Campeas, R; Fyer, AJ; Gorman, JM; Levin, A; Liebowitz, MR, 1986) |
| "The hallmark of agoraphobia is the spontaneous panic attack, a reaction of extreme fearfulness and impending doom with cardiorespiratory symptoms." | 1.26 | Current drug therapy for agoraphobia. ( Ravaris, CL, 1981) |
| "Phenelzine is an excellent agent for treating ambulatory patients with neurotic depression and those with agoraphobia and social phobias." | 1.26 | Use of MAOI antidepressants. ( Bartlett, D; Ives, JO; Nies, A; Ravaris, CL; Robinson, DS, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (56.58) | 18.7374 |
| 1990's | 25 (32.89) | 18.2507 |
| 2000's | 6 (7.89) | 29.6817 |
| 2010's | 2 (2.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, ML | 1 |
| Smits, JA | 1 |
| Hofmann, SG | 1 |
| Blanco, C | 2 |
| Heimberg, RG | 7 |
| Schneier, FR | 11 |
| Fresco, DM | 1 |
| Chen, H | 1 |
| Turk, CL | 1 |
| Vermes, D | 1 |
| Erwin, BA | 1 |
| Schmidt, AB | 1 |
| Juster, HR | 4 |
| Campeas, R | 8 |
| Liebowitz, MR | 20 |
| Berger, I | 1 |
| Jaworowski, S | 1 |
| Gross-Tsur, V | 1 |
| Aarre, TF | 1 |
| Schmidt, A | 1 |
| Blanco-Jerez, CR | 1 |
| Marshall, RD | 3 |
| Sánchez-Lacay, A | 1 |
| Solyom, C | 2 |
| Solyom, L | 2 |
| LaPierre, Y | 1 |
| Pecknold, J | 1 |
| Morton, L | 1 |
| Telch, MJ | 1 |
| Tearnan, BH | 1 |
| Taylor, CB | 1 |
| Tyrer, P | 6 |
| Koczkas, S | 1 |
| Holmberg, G | 1 |
| Wedin, L | 1 |
| Berrios, GE | 1 |
| Morley, SJ | 1 |
| Van Winter, JT | 1 |
| Stickler, GB | 1 |
| Matuzas, W | 1 |
| Glass, RM | 1 |
| Jenike, MA | 1 |
| Surman, OS | 2 |
| Cassem, NH | 1 |
| Zusky, P | 1 |
| Anderson, WH | 1 |
| Evans, DL | 1 |
| Kalina, K | 1 |
| Fier, M | 1 |
| Gardner, M | 1 |
| Lambourn, J | 1 |
| Whitford, M | 1 |
| Davis, JM | 1 |
| Nasr, S | 1 |
| Spira, N | 1 |
| Vogel, C | 1 |
| Sheehan, DV | 4 |
| Curtis, GC | 1 |
| Cameron, OG | 1 |
| Nesse, RM | 1 |
| Pohl, R | 1 |
| Berchou, R | 1 |
| Rainey, JM | 1 |
| Ballenger, J | 1 |
| Jacobsen, G | 1 |
| Ravaris, CL | 3 |
| Engelberg, B | 1 |
| Warneke, L | 1 |
| Van Ameringen, M | 1 |
| Mancini, C | 1 |
| Streiner, D | 1 |
| Fallon, BA | 2 |
| Feerick, J | 2 |
| Oberlander, EL | 1 |
| Oberlander, E | 1 |
| Schneier, F | 3 |
| Golwyn, DH | 2 |
| Sevlie, CP | 1 |
| Clarvit, SR | 1 |
| Shear, MK | 1 |
| Beidel, DC | 1 |
| Hope, DA | 2 |
| Holt, CS | 3 |
| Welkowitz, LA | 2 |
| Bruch, MA | 2 |
| Cloitre, M | 1 |
| Fallon, B | 1 |
| Klein, DF | 3 |
| Otto, MW | 1 |
| Thyer, BA | 1 |
| Davies, S | 2 |
| Goetz, D | 2 |
| Lin, SH | 1 |
| Coupland, NJ | 1 |
| Steinberg, D | 1 |
| Mountjoy, CQ | 1 |
| Roth, M | 1 |
| Garside, RF | 1 |
| Leitch, IM | 1 |
| Robinson, DS | 2 |
| Nies, A | 2 |
| Ives, JO | 2 |
| Bartlett, D | 2 |
| Quitkin, F | 1 |
| Rifkin, A | 1 |
| Paykel, ES | 1 |
| Parker, RR | 1 |
| Penrose, RJ | 1 |
| Rassaby, ER | 1 |
| Versiani, M | 1 |
| Nardi, AE | 1 |
| Mundim, FD | 1 |
| Alves, AB | 1 |
| Amrein, R | 1 |
| Carrasco, JL | 1 |
| Hollander, E | 7 |
| Hatterer, J | 2 |
| Fyer, A | 2 |
| Gorman, J | 2 |
| Papp, L | 4 |
| Gully, R | 1 |
| Saoud, JB | 1 |
| Street, L | 1 |
| Gitow, A | 1 |
| Sweet, RA | 1 |
| Gelernter, CS | 1 |
| Uhde, TW | 2 |
| Cimbolic, P | 1 |
| Arnkoff, DB | 1 |
| Vittone, BJ | 1 |
| Tancer, ME | 2 |
| Bartko, JJ | 1 |
| Weinstock, RC | 1 |
| Hatterer, JA | 1 |
| Gorman, JM | 3 |
| Fyer, AJ | 4 |
| Campeas, RB | 1 |
| Papp, LA | 1 |
| Murphy, S | 1 |
| Scrignar, CB | 1 |
| Pecknold, JC | 1 |
| Levin, AP | 1 |
| Sandberg, D | 2 |
| Levin, A | 2 |
| Shea, CA | 1 |
| Williams, J | 1 |
| Strom, TB | 1 |
| Jones, KJ | 1 |
| Coleman, J | 1 |
| Buigues, J | 1 |
| Vallejo, J | 1 |
| Zisook, S | 1 |
| Kelly, D | 3 |
| Lerner, J | 1 |
| Candy, J | 2 |
| Heseltine, GF | 1 |
| McClure, DJ | 1 |
| Ledwidge, B | 1 |
| Steinberg, G | 1 |
| Tyrer, TP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Neurocognitive and Neuroimaging Variables Associated With Response to Treatment in Patients With OCD[NCT03993535] | Phase 4 | 250 participants (Actual) | Interventional | 2018-10-10 | Active, not recruiting | ||
| Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety[NCT00177008] | Phase 4 | 18 participants | Interventional | 2004-03-31 | Completed | ||
| Mobile-based Attentional Bias Modification Training (ABMT) for Socially Anxious Individuals[NCT06054386] | 60 participants (Anticipated) | Interventional | 2022-04-07 | Recruiting | |||
| fMRI of Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder[NCT02036658] | 108 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| Evaluation of Nonsurgical Periodontal Treatment in Patients With Social Phobia: a Randomized Controlled Clinical Trial[NCT03241277] | 45 participants (Anticipated) | Interventional | 2017-10-05 | Not yet recruiting | |||
| Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia[NCT01394471] | Phase 1 | 68 participants (Actual) | Interventional | 2011-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for phenelzine and Claustrophobia
| Article | Year |
|---|---|
Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Humans; Monoamine Oxidase Inhibitors; Pa | 2014 |
Selective mutism: a review of the concept and treatment.
Topics: Anxiety; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Mutism; Phenelzine; Phobic Disorders; Pre | 2002 |
Pharmacological treatment of social anxiety disorder: a meta-analysis.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Anxiety Disorders; C | 2003 |
Antidepressant medication in the treatment of agoraphobia: a critical review.
Topics: Agoraphobia; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine | 1983 |
Current concepts in psychiatry. Panic attacks and phobias.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Clinical | 1982 |
Medication therapy for social phobia.
Topics: Benzamides; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modali | 1994 |
Issues in the design of trials for the evaluation of psychopharmacological treatments for social phobia.
Topics: Clinical Trials as Topic; Humans; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Resear | 1996 |
Psychotherapy in the overall management strategy for social anxiety disorder.
Topics: Behavior Therapy; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; | 1998 |
Cognitive-behavioral therapy for social anxiety disorder: model, methods, and outcome.
Topics: Clinical Trials as Topic; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Human | 1999 |
Social phobia: etiology, neurobiology, and treatment.
Topics: Brain; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnostic Imaging; Dopamine; | 2001 |
Current status of psychotherapeutic interventions for social phobia.
Topics: Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; M | 2001 |
Treatment of social phobia with antidepressants.
Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Drug Approval; Humans; Moclobemide; Mono | 2001 |
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side | 1985 |
A clinical overview of monoamine oxidase inhibitors.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Body Weight; Depressive Disorder; Dose-Response | 1985 |
29 trials available for phenelzine and Claustrophobia
| Article | Year |
|---|---|
A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.
Topics: Adolescent; Adult; Aged; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnostic and Sta | 2010 |
Phenelzine efficacy in refractory social anxiety disorder: a case series.
Topics: Adult; Female; Humans; Male; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Psychiatric | 2003 |
Phenelzine and exposure in the treatment of phobias.
Topics: Adolescent; Adult; Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Double-Blind Method; | 1981 |
Clinical and pharmacokinetic factors affecting response to phenelzine.
Topics: Anxiety Disorders; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Double-Bl | 1980 |
Anxiety: differential diagnosis and treatment from a biologic perspective.
Topics: Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Diagnosis, Differential; Diazepam; Double- | 1981 |
Current concepts in psychiatry. Panic attacks and phobias.
Topics: Adolescent; Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Clinical | 1982 |
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
Topics: Adult; Anxiety; Depression; Double-Blind Method; Female; Humans; Hypochondriasis; Hysteria; Imiprami | 1980 |
Self selection and sample selection in a treatment study of social phobia.
Topics: Adult; Bias; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Patient Acceptance of | 1995 |
Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.
Topics: Adult; Analysis of Variance; Animals; Cognitive Behavioral Therapy; Combined Modality Therapy; Femal | 1998 |
Cognitive behavioral group therapy and phenelzine both effective in social phobia.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follo | 1999 |
Symptomatic treatment of agoraphobia and social phobias: a follow-up study.
Topics: Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents; Clinical Trials as Topic; Desensitization, | 1975 |
A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Agoraphobia; Anxiety Disorders; Clinical Trials as To | 1977 |
Clinical pharmacology of phenelzine.
Topics: Acetylation; Acetyltransferases; Adjustment Disorders; Amitriptyline; Blood Platelets; Clinical Tria | 1978 |
Monoamine oxidase inhibitors. A review of antidepressant effectiveness.
Topics: Acetylation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Blood Platelets; Depression; Human | 1979 |
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
Topics: Adult; Benzamides; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; | 1992 |
Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.
Topics: Adolescent; Adult; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inv | 1992 |
Potential interactions between monoamine oxidase inhibitors and prescribed dietary supplements.
Topics: Adult; Diet, Reducing; Food, Fortified; Humans; Male; Monoamine Oxidase Inhibitors; Phenelzine; Phob | 1991 |
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
Topics: Adolescent; Adult; Alprazolam; Ambulatory Care; Behavior Therapy; Cognitive Behavioral Therapy; Doub | 1991 |
Phenelzine and atenolol in social phobia.
Topics: Adolescent; Adult; Atenolol; Double-Blind Method; Female; Humans; Male; Phenelzine; Phobic Disorders | 1990 |
Pharmacotherapy of four men with paruresis.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Phenelzine; Phobic Dis | 1990 |
Efficacy of combined antidepressant therapy in resistant neurotic disorder.
Topics: Adult; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Diazepam; Do | 1990 |
Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
Topics: Adult; Atenolol; Clinical Trials as Topic; Female; Humans; Male; Outcome and Process Assessment, Hea | 1988 |
Pharmacotherapy of social phobia. A condition distinct from panic attacks.
Topics: Adult; Atenolol; Clinical Trials as Topic; Humans; Male; Phenelzine; Phobic Disorders | 1987 |
Immunological response to stress in agoraphobia and panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Fear; | 1986 |
Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
Topics: Adolescent; Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Sch | 1987 |
Phenelzine in phobic states.
Topics: Acetylation; Anxiety; Aversive Therapy; Clinical Trials as Topic; Desensitization, Psychologic; Fema | 1973 |
Phenelzine in phobic anxiety: a controlled trial.
Topics: Anxiety; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; Male; Phenelzine; Ph | 1973 |
A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety.
Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Female; Humans; Male; Personality Assessment; Ph | 1973 |
Behaviour therapy versus drug therapy in the treatment of phobic neurosis.
Topics: Adult; Anxiety; Aversive Therapy; Behavior Therapy; Electroshock; Evaluation Studies as Topic; Femal | 1973 |
34 other studies available for phenelzine and Claustrophobia
| Article | Year |
|---|---|
Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Female; Humans; Mal | 1984 |
A pilot study of the effect of the 5-HT-uptake inhibitor, zimelidine, on phobic anxiety.
Topics: Adolescent; Adult; Anxiety; Body Weight; Brompheniramine; Electrocardiography; Humans; Middle Aged; | 1981 |
Koro-like symptom in a non-Chinese subject.
Topics: Adult; Agoraphobia; Anxiety Disorders; England; Humans; Male; Panic; Penis; Phenelzine; Phobic Disor | 1984 |
Panic attack syndrome.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Child; Fear; Humans; Hyperven | 1984 |
Treatment of agoraphobia and panic attacks.
Topics: Agoraphobia; Anxiety Disorders; Behavior Therapy; Double-Blind Method; Fear; Humans; Imipramine; Pan | 1983 |
Monoamine oxidase inhibitors in obsessive-compulsive disorder.
Topics: Adult; Anxiety Disorders; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Panic; P | 1983 |
Effect of phenelzine on the prolapsed mitral valve in a patient with agoraphobia with panic attacks.
Topics: Agoraphobia; Electrocardiography; Female; Humans; Middle Aged; Mitral Valve Prolapse; Panic; Phenelz | 1983 |
Agoraphobia: the 'what if' syndrome.
Topics: Adolescent; Adult; Agoraphobia; Female; Humans; Imipramine; Male; Phenelzine; Phobic Disorders; Psyc | 1981 |
The dexamethasone suppression test in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Depressive Disorder; Dexamethasone; Diagnosis, Differential; | 1982 |
Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Clomipramine; Diazepam; Double-Blind Method; Humans; | 1982 |
Current drug therapy for agoraphobia.
Topics: Adult; Agoraphobia; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Imipramine; Ph | 1981 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; C | 1994 |
Phenelzine and sexuality.
Topics: Adult; Exhibitionism; Homosexuality; Humans; Male; Paraphilic Disorders; Phenelzine; Phobic Disorder | 1994 |
Sertraline in social phobia.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety Disorders; Comorbidity; Depressive Disorder; | 1994 |
Physical disability and social phobia.
Topics: Adult; Disabled Persons; Female; Humans; Male; Middle Aged; Phenelzine; Phobic Disorders | 1994 |
Treatment of stuttering with phenelzine.
Topics: Adult; Combined Modality Therapy; Humans; Male; Phenelzine; Phobic Disorders; Psychotherapy; Stutter | 1993 |
Adventitious change in homosexual behavior during treatment of social phobia with phenelzine.
Topics: Adult; Homosexuality; Humans; Male; Phenelzine; Phobic Disorders; Sexual Behavior | 1993 |
The offensive subtype of Taijin-kyofu-sho in New York City: the phenomenology and treatment of a social anxiety disorder.
Topics: Adolescent; Adult; Anxiety Disorders; Benzamides; Clonazepam; Culture; Diagnosis, Differential; Ethn | 1996 |
Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Cognitive Behavioral Therapy; Confounding Fact | 1999 |
Depressive classification and prediction of response to phenelzine.
Topics: Adolescent; Adult; Aged; Anxiety; Depression; Female; Hostility; Humans; Male; Middle Aged; Outpatie | 1979 |
Use of MAOI antidepressants.
Topics: Adjustment Disorders; Diet; Humans; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Time | 1978 |
Treatment outcome of obsessive compulsive disorder with comorbid social phobia.
Topics: Adult; Clomipramine; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsess | 1992 |
Treatment of social phobia with drugs other than benzodiazepines.
Topics: Adolescent; Atenolol; Benzamides; Buspirone; Child; Clinical Trials as Topic; Female; Fluoxetine; Hu | 1991 |
Phenelzine treatment of elective mutism: a case report.
Topics: Child, Preschool; Constipation; Diagnosis, Differential; Drug Administration Schedule; Female; Human | 1990 |
Postpanic anxiety disorder: diagnosis and treatment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Athletic Injuries; Benzodiazepines; Desen | 1986 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Social phobia.
Topics: Adrenergic beta-Antagonists; Arousal; Atenolol; Behavior Therapy; Epinephrine; Humans; Interpersonal | 1987 |
Behavioural and combined therapy in panic states.
Topics: Agoraphobia; Anxiety Disorders; Behavior Therapy; Cognition; Combined Modality Therapy; Desensitizat | 1987 |
Sexual dysfunction related to alprazolam treatment of social phobia.
Topics: Adult; Alprazolam; Ejaculation; Female; Humans; Male; Middle Aged; Orgasm; Phenelzine; Phobic Disord | 1988 |
Agoraphobia.
Topics: Agoraphobia; Alprazolam; Anxiety, Separation; Behavior Therapy; Combined Modality Therapy; Humans; I | 1987 |
Phenelzine in social phobia.
Topics: Adolescent; Adult; Female; Humans; Interpersonal Relations; Male; Middle Aged; Phenelzine; Phobic Di | 1986 |
Agoraphobia.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Behavior Therapy; Benzodiazepines; Female; Humans; Phenelzi | 1974 |
[Phenelzin in agoraphobia].
Topics: Adult; Agoraphobia; Female; Humans; Phenelzine; Phobic Disorders | 1974 |
Letter: Agoraphobia.
Topics: Agoraphobia; Chlordiazepoxide; Dibenzazepines; Humans; Opipramol; Phenelzine; Phobic Disorders; Prop | 1974 |
Are monoamine-oxidase inhibitors antidepressants?
Topics: Depression; Female; Humans; Male; Monoamine Oxidase Inhibitors; Neurotic Disorders; Phenelzine; Phob | 1973 |